STOCK TITAN

GINKGO BIOWORKS HLDGS WTS (DNABW) Stock Price, News & Analysis

DNABW OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
126 218 sessions, September 2, 2025 to September 2, 2026
Largest daily move
+266.7% close of June 18, 2026
1-year change
-98.7% closing prices, September 2, 2025 to September 2, 2026

Company Description

DNABW has declined 98.7% over the past year. The last closing price was $0.0001.

For FY2025, GINKGO BIOWORKS HLDGS WTS reported revenue of $170.2M with net income of -$313K and diluted earnings per share of -$5.64. The company operates at a net profit margin of -0.2%.

This page collects what Stock Titan holds for DNABW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-98.7%
Performance 1 year

GINKGO BIOWORKS HLDGS WTS (DNABW) closed at $0.0001 on September 2, 2026. Over the past 12 months, the price has lost 98.7%.

See what a $1,000 investment in DNABW would be worth today

DNABW Metrics & Rankings

Month to date
-50.0%
View ranking
YTD
-98.0%
View ranking

Price returns through September 2, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for DNABW.

SEC Filings

GINKGO BIOWORKS HLDGS WTS has filed 5 recent SEC filings, including 2 Form 144, 1 Form 4, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on August 25, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DNABW SEC filings →

Financial Highlights

GINKGO BIOWORKS HLDGS WTS generated $170.2M in revenue in FY2025, operating income reached -$315.3M (-185.3% operating margin), and net income was -$313K, reflecting a -0.2% net profit margin. Diluted earnings per share stood at -$5.64. The company generated -$171.1M in operating cash flow. With a current ratio of 4.92, the balance sheet reflects a strong liquidity position.

$170.2M
Revenue (FY2025)
-$313K
Net Income (FY2025)
-$171.1M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in GINKGO BIOWORKS HLDGS WTS (DNABW) currently stands at 10.9 thousand shares. Since September 2025, short interest has decreased by 72.6%.

Days to Cover History

Last 12 Months

Days to cover for GINKGO BIOWORKS HLDGS WTS (DNABW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

Frequently Asked Questions

What is the current quoted price of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The current quoted price of GINKGO BIOWORKS HLDGS WTS (DNABW) is $0.0001 as of September 11, 2026.

What is the revenue of GINKGO BIOWORKS HLDGS WTS (DNABW) stock?

The FY2025 revenue of GINKGO BIOWORKS HLDGS WTS (DNABW) is $170.2M, from its most recent completed fiscal year.

What is the net income of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The FY2025 net income of GINKGO BIOWORKS HLDGS WTS (DNABW) is -$313K, from its most recent completed fiscal year.

What is the earnings per share (EPS) of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The diluted earnings per share (EPS) of GINKGO BIOWORKS HLDGS WTS (DNABW) is -$5.64 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The operating cash flow of GINKGO BIOWORKS HLDGS WTS (DNABW) is -$171.1M. Learn about cash flow.

What is the profit margin of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The net profit margin of GINKGO BIOWORKS HLDGS WTS (DNABW) is -0.2%. Learn about profit margins.

What is the operating margin of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The operating profit margin of GINKGO BIOWORKS HLDGS WTS (DNABW) is -185.3%. Learn about operating margins.

What is the current ratio of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The current ratio of GINKGO BIOWORKS HLDGS WTS (DNABW) is 4.92, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of GINKGO BIOWORKS HLDGS WTS (DNABW)?

The operating income of GINKGO BIOWORKS HLDGS WTS (DNABW) is -$315.3M. Learn about operating income.